Drive Life Science Growth Across Europe.

Europe is one of the world’s most established pharmaceutical regions, combining deep scientific heritage with cutting-edge innovation in biologics, advanced therapies, and precision medicine. With strong regulatory alignment and seamless cross-border collaboration, it offers a powerful platform for scaling R&D and manufacturing.

Flexible Partnership Models

Select the structure that aligns with your capital plan:

• Leasing – operating leases to suit your needs.

• Project Finance – milestone-based funding that scales with your pipeline.

• Rent-to-Own – build equity in critical facilities while you innovate.

Who We Serve

• Global and domestic pharmaceutical companies scaling clinical or commercial production.

• Public and private research institutes driving next-generation biologics.

• Leading universities advancing translational science and talent development.

Why APAC?

• World-class bio-clusters – Cambridge (UK), Ireland, Basel (Switzerland), Berlin, and the Nordic hubs provide dense ecosystems of talent, capital, and suppliers.

• Integrated market access – the European Union enables streamlined movement of goods, talent, and IP across 25+ countries.

• Strong regulatory framework – EMA approvals are globally respected and support multi-country clinical pathways.

• Attractive incentives – generous R&D tax credits, grants, and innovation funds across key markets.

• Highly skilled workforce – deep expertise in biologics, advanced therapies, and precision manufacturing.

Let’s Propel Discovery - Together

From green-field builds to capacity expansions to R&D, our team stands ready to make your European strategy seamless. Connect with us today to see how we can power your next breakthrough.